One thing shareholders should be very leary of is: If, as Somewey says this is all a ruse to move share into stronger hands; watch out for an AH deal before any Urocidin deals. If that happens, I'm sure a big number of shareholders will sell share on the cheap, because of a significant pop in SP and unsure about a viability of Urocidin still. If a Urocidin deal happens first then the SP will be a completely different animal.
With a 30mm up front US deal, the market will place a value on Urocidin (currently 0). What that is, I don't know, maybe .60 to .80 cents on top of our current SP. After that the market can factor in EU and Asia with a simple extrapolation. eg. 30mm US = 35mm for EU, 20mm for the far east.Then an AH sale of 100mm should be worth $1 on top of that. Without a Urocidin deal, an AH sale might be worth .50 on the dollar. (the Graeme algorithm) If Somewey is correct, that will be the last chance the current crew has to "stick it" to the grumpy shareholder base.
I will not vote for an AH sale, without there being a Urocidin deal in place, or a dividend. None of you should either!!!!! I am not talking .10 dividend either.
beech